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This monograph forms part of a series of disease monographs commissioned by the 
International Development Research Centre over the period Nov 2015 to April 2016 to 
inform funding priorities for the Livestock Vaccine Innovation Fund (LVIF). The LVIF is a 
seven-and-a-half year, CA$57 million partnership between the Bill & Melinda Gates 
Foundation, Global Affairs Canada and Canada’s International Development Research 
Centre. It focuses on those animal diseases posing the greatest risk to poor livestock 
keepers in Sub-Saharan Africa, South and Southeast Asia, targeting transboundary 
diseases to achieve lasting regional impact. 
 
The content presented here is as submitted by the consultant(s) involved and has been 
edited for appearance only. The views, information, or opinions expressed in this 
monograph are solely those of the individual consultant(s) involved and do not 
necessarily represent those of the Bill & Melinda Gates Foundation, Global Affairs Canada 
and International Development Research Centre, or any of their employees. Sections of 
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ASEAN  Association of South East Asian Nations 
C  Chinese ‘C’ strain 
DIVA   Differentiating infected from vaccinated animals 
dpi  Days post infection 
E  Envelope proteins (E, E1, and E2) 
Erns  E0 glycoprotein 
ELISA  Enzyme-linked immunosorbent assay 
FAO  Food and Agriculture Organization of the United Nations 
FAT  Fluorescent antibody test 
FAVN  Fluorescent antibody virus neutralization test  
GPE–  Japanese guinea-pig exaltation-negative strain 
Npro  N-terminal autoprotease 
NPLA  Neutralising peroxidase-linked assay 
NS  Nonstructural protein 
NTR  Non-translated region 
OIE  World Organization for Animal Health 
p7  Virus ionic channel protein 
PK  Porcine kidney cell culture 
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PAV  Live attenuated Mexican strain 
PRRS  Porcine Respiratory and Reproduction Syndrome virus 
PRV  Pseudorabies virus (Aujesky’s disease) 
RT-PCR  Reverse transcription polymerase chain reaction 
SAARC  South Asia Association for Regional Cooperation 
TADs  Transboundary animal diseases 
USA  United States of America 
VI  Virus isolation 
WAHID  Interface for the World Animal Health Information System 
WAHIS  World Animal Health Information System Database 
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Classical swine fever virus (CSFV) is a small, enveloped RNA virus in the genus Pestivirus of the family 
Flaviviridae.  CSFV is related to the other pestiviruses, including bovine viral diarrhea virus of cattle and border 
disease virus of sheep [1][2]. Congenital infections with ruminant pestiviruses in pigs occasionally give rise to a 
clinical disease that is indistinguishable from classical swine fever (CSF) [2]. The genome of CSFV includes 12 
proteins including the capsid protein C and three envelope proteins (Erns, E1, and E2). Both Erns and E2 are known 
to induce viral neutralizing antibodies, which give protective immunity in the pigs [5]. All CSFV react as a single 
serotype and are classified into three major genotypes and ten subtypes (sub-genotypes) [4].  Most of the highly 
virulent CSFV strains belong to genotype 1 which also includes the vaccine strains. Moderately virulent strains 
belong to genotypes 2 and 3. 
The CSF viruses affect domesticated pigs and wild boars with variable symptoms according to the virus strain, 
exposure history and host genetics [2][3]. The clinical signs of CSFV are not pathognomonic and include an acute 
form, a chronic form and a congenital form. The incubation period of CSFV in pigs is 2-14 days [1][4].  The virus 
replicates in the tonsils and regional lymph nodes, after which viral shedding from faeces and urine begins 6-9 
days post-infection [10]. Both direct and indirect transmission can follow. Direct transmission can be from 
horizontal and vertical transmission.  Indirect transmission can also occur via humans, transported vehicles, 
artificial insemination, pork and pork products and fomites [14][10]. Congenitally infected piglets and chronically 
infected adult pigs act as long term silent carriers of CSFV with suppressed antibody production in chronically 
infected piglets.  The European wild boar acts as a non-classical reservoir for CSFV.  Information about the role 
of wild and feral pigs in Asia is lacking. 
CSFV is the highest impact pig disease accounting for the greatest global pig losses measured in livestock units 
lost [37].  There were a total of 4,938 CSFV events reported by the 20 selected countries under the Livestock 
Vaccine Innovation Fund (LVIF) between 2000 and 2015.  Forty-eight per cent (48%) of all CSFV events were 
reported in Viet Nam while 42% were reported in India.  Nepal (5%), Madagascar (2%), South Africa (2%) and 
Myanmar (1%) accounted for the remainder of the reported events.  The method of choice for detecting herds 
early in infection is to collect whole blood and tissues from febrile or recently dead animals.  Recommended 
tissues to collect include tonsil, lymph nodes (pharyngeal, mesenteric), spleen, kidney, distal ileum, blood in 
EDTA or in Heparin tubes (live cases).  The virus can survive in the environment, for three days at 50°C and 7-15 
days at 37°C.  It can survive for years at -70°C.  Rapid temperature changes are harmful. The CSFV can survive for 
90 days in frozen meat and 188 days in ham [11].   
CSFV is reported in Europe, Central and South America, the Caribbean and Asia either through epidemics of 
particular strains or as an endemically established disease, which results in high mortality in pigs and wild boars 
[7][8].  The main risks for transmission of CSFV include the movement of pigs that are incubating the disease or are 
persistently infected; indirect spread of virus through transport vehicles; human contacts; and feeding uncooked 
pork wastes.  
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Culling remains the most effective way to control CSFV. However, this method is not sustainable or acceptable 
for developing countries. Vaccination remains the preferred tool for prevention and control for smallholder pig 
production units.  The most common vaccine strain used globally is the Chinese ‘C’ strain. The GPE– strain, the 
Thiverval strain, and the Mexican PAV strains are regionally applied [47].  The subunit marker vaccines based on 
the E2 protein have also been developed.  All strains noted have DIVA capability except for the Chinese C strain.   
An effective strategy for CSFV vaccination for pig smallholders should consider the following elements: 
• Appropriate enabling mechanisms are in place at regional, national and local levels; 
o National policies for pig production, animal identification, regulations and contingency plans for 
CSF, including zoning and compartmentalization; 
o Laboratory and epidemiological capacity for seromonitoring and virus surveillance programs; 
o On going communication and information sharing among public and private sectors; 
o Risk assessments and cost-benefit studies to evaluate the use of culling and vaccination; 
• Evaluate the presence of important immunosuppressive disease agents such as PRRS; 
• Utilize the appropriate type of vaccines under the following epidemiological contexts: 
o Free areas of CSFV with Trade Access: emergency vaccination scenarios [34]; 
o Endemic Areas:  Modified live ‘C’ type vaccine routine use in endemic areas or alternatively, use 
of E2 subunit vaccines [34]; 
o Emergency Scenarios: Rapid diagnosis and combined use of culling and emergency ring 
vaccination [40][42];  
o Progressive elimination and freedom from CSFV: development and use of C strain marker 
vaccines [3]. 
The key gaps and solutions that need to be addressed prior to developing a potential vaccine: 
Short term 
• Assess and optimize the existing C strain tissue culture lines for wider use; 
• Build vaccine production capacity for thermostable cell culture C strain vaccine based on tissue culture 
to increase vaccine production capacity, especially in India and Viet Nam; 
• Conduct field trials with documented assessments to test the effectiveness of vaccines and diagnostic 
tests;  
• Conduct pilot projects that include education of veterinarians, paraveterinarians and farmers on the 
proper use and application of vaccines and diagnostic tests. 
Medium term 
• Support the development of C strain vaccines with DIVA capability with the private sector involvement 
for cost effective and sustainable eradication of CSF; 
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• Develop a cheap and effective test kit for virus detection for smallholders to meet the challenge of the 
predominant genotypes in Asia from the acute form (genotype 1) to the chronic form (genotype 2) 
which results in silent carriers. 
• Conduct epidemiological research and risk assessments in Asia at the interface of commercial pig - 
smallholder pig production units - wild boar and feral pigs; 
Long term 
• Further develop subunit marker vaccines that can eliminate all three genotypes; 
• Continue basic research immunological properties of all C strain vaccines and subunit marker vaccines;  
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The CSF viruses primarily affect domesticated pigs and wild boars with variable symptoms according to the virus 
strain [3][2].  While all CSFV react as a single serotype, they are classified into three major genotypes and ten 
subtypes (sub-genotypes) [4].   The virion is enveloped, spherical and about 50 nm in diameter. 
Virus structure 
Classical swine fever virus (CSFV) is a small (12kb), enveloped RNA virus in the genus Pestivirus of the family Flaviviridae.  
CSFV is antigenically related to the other pestiviruses, including bovine viral diarrhea virus (BVD; including BVDV-1 and 
BVDV-2) of cattle; to border disease virus (BDV including BDV -1, BDV-2, BDV-3) of sheep; and to a single pestivirus, 
which was isolated from a giraffe [1][2]. These related pestiviruses are highly prevalent in bovine and ovine populations 
and can infect pigs.  In addition, congenital infections with ruminant pestiviruses in pigs occasionally give rise to a 
clinical disease that is indistinguishable from classical swine fever (CSF) [2].  The genetic and serotypical characteristics of 
pestiviruses vary among species. 
 
Figure 1:  Structure of classical swine fever virus (http://viralzone.expasy.org/all_by_species/39.html) 
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Figure 2: Classical swine fever genome 
 
The genome of CSFV includes 12 proteins arranged in the order in Figure 2 Npro refers to an Npro and E is a 
glycoprotein with ribonuclease activity.  The structural proteins include the capsid protein C and three envelope 
proteins (Erns, E1, and E2).  The Erns (E0) glycoprotein lacks the membrane anchor and is secreted from infected 
cells and may take part in the initial attachment process of viral entry, rather than in the specific binding or 
fusion process.  The Erns may also play an important role in the post-entry stages, which may be a possible 
reason causing the CSFV with Erns deletion to be non-transmissible [5].  E2 is the major neutralizing antigen for 
CSFV infection, while Erns is considered to be the secondary glycoprotein that mediates neutralization [5]. The Erns 
is unique to Pestiviruses, and has been implicated in the evasion of host interferon (IFN) responses [5].  The NTR 
is most likely involved in initiation of genomic replication as well as being involved in the coordination of the 
viral translation and replication. The remaining proteins are considered nonstructural and may play an 
important role in the process of viral replication (NS) [2].  Virus assembly is facilitated by the viral ionic channel p7 
and the new virions are released by exocytosis. The key interactions between elements of the virus genome and 
the host include the attachment of the viral envelope protein E components to host receptors, which initiate 
entry into the host cell by clathrin-mediated endocytosis. Both Erns and E2 are known to induce viral neutralizing 
antibodies, which give protective immunity in the pigs [5]. Segregation of pestiviruses into species and subgroups 
is done on the basis of complete Npro and E2 coding genes and pestiviruses can also be categorized into 7 major 
groups based on differentiation of the Npro and E genes (Figure 3) [2].   By comparing one-step growth curves of 
infectious cell-associated and secreted virus from various CSFV strains, one study identified in vitro parameters 
in PK cell culture correlating with the virulence of the respective virus strain in pigs [6].  The ratio of cell-
associated virus versus secreted virus proved to be considerably lower for the highly virulent strains when 
compared to avirulent or moderately virulent strains [6]. 
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Figure 3: Phylogenetic relationships of pestiviruses (including CSFV) based on Npro and E genes 
 
The CSFV is moderately fragile and does not persist in the open environment. It can survive 3 days at 50°C and 7-
15 days at 37°C and is sensitive to drying and ultraviolet light but survives well in pens during cold conditions (up 
to 4 weeks in winter). The CSFV can survive in pig meat during salt curing and smoking for 17 and for at least 180 
days, respectively, depending on the process used. The virus persists 3–4 days in decomposing organs and 15 




CSFV is reported in Europe, Central and South America, the Caribbean and Asia either as an endemically 
established disease or through epidemics of particular strains, resulting in the death of susceptible pigs and wild 
boars [7][8]. Table 1 summarizes key epidemiological features of CSF disease to be further explained in greater 
detail under agent, host and environmental factors below [4]. 
The first recorded outbreaks of a disease of pigs consistent with classical swine fever or hog cholera occurred in 
1822 in France and 1833 in Ohio, USA [7].   These continental epizootics are likely linked via international trade of 
infected pigs or contaminated imported meat.  Eventually CSFV was established in both Europe and North 
America by the 1860’s and by 1903, the transmission via filtrates from infected animals given to susceptible 
animals was demonstrated. The development and application of a crystal violet inactivated vaccine, an 
attenuated live virus vaccine and a subunit marker vaccine occurred in 1934, 1951 and 1996, respectively [7]. 
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In 1888, the first cases of CSFV were reported in Japan [7].  In 1996, an eradication program in Japan was initiated 
in three phases:   




• The European wild boar acts as non-classical reservoir hosts since they can also be 
clinically affected depending on the CSFV strain 
• The role of wild boar in Asia is not established 
Natural hosts 
demonstrating symptoms 
• Domestic pigs (Sus domesticus),  
• Feral pigs  
• Wild boar  
Host and vector • Natural susceptible hosts, including domestic pigs adults and congenitally infected 
newborns), feral pigs and European wild boar 
Transmission • Oral and oronasal route 
• Direct transmission between sick and healthy animals 
• Transplacental transmission to piglets who can become asymptomatic carriers 
• Human spread – veterinarians, paraveterinarians, pig traders and visitors 
• Very localized spread via wind within 1km has been recorded 
• Indirect transmission by feeding waste products material containing infected meat 
(CSFV can remain infectious for 3–6 months in meat) 
• Fomites (premises, vehicles, implements, clothes) 
• Congenitally infected piglets can shed the virus silently for 6-12 months prior to 
death 
Virus sources • Blood, semen, secretions, excretions and tissues, from inapparently infected adult 
pigs, sick and dead pigs 
• Congenitally infected piglets 
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Phase 1:  A 2-year program was initiated to immunize the pig population by vaccination (as close to 100% as 
possible);  
Phase 2: To establish CSF-free local areas without vaccination and to confirm that the area is free of CSF field 
viruses;  
Phase 3: To suspend vaccination completely and to confirm that the pig population is free of CSF.  
Though it was eradicated from Japan, CSFV remains endemic and is reported throughout east, southeast and 
south Asia.  Factors underlying the lack of success in disease control are the lack of funds for vaccination, and in 
some countries limited expertise and diagnostic facilities to ensure adequate herd immunity [7].  Currently, CSF 
still occurs sporadically or remains endemic in many regions of China [9]. 
The incubation period of CSFV in the pig host is 2-14 days [1][4].  Following ingestion in the pig host, the CSFV 
replicates in the tonsils and through the regional lymph nodes, after which viral shedding from faces and urine 
begins 6-9 days post-infection [10].   The natural infection route is oronasal although conjunctival, genital and 
parenteral routes also exist.  The minimal amount of viral particles required for infection is route-dependent and 
low viral doses (up to 10 TCID50) are sufficient [10].  The virus can survive in the environment, for three days at 
50°C and for 7-15 days at 37°C.  It can survive for years at -70°C. The CSFV can survive for 90 days in frozen meat 
and 188 days in ham [11].  Rapid temperature changes are harmful.  It can survive between 4 days and 4 weeks in 
manure depending on temperature and other environmental factors [11].   
Both direct and indirect transmission of CSFV are important mechanisms for its spread. Direct transmission can 
be from horizontal and vertical transmission.  Indirect transmission occurs via humans, transport vehicles, 
artificial insemination and fomites [10].  The Basic Reproductive Number (R0) is a mathematical ratio, which 
describes the rate of secondary disease spread from following a primary case. For example, an R0 of 4 indicates 
that each primary case generates 4 secondary cases. Table 2 summarizes R0 values for CSFV transmission under 
various epidemiological contexts [10][12][13]. 
 
Table 2: R0 values for CSFV transmission under various epidemiological contexts 
 
R0 values (95% CI) Context References 
100 (54.4–186) Weaner pigs within-pen estimate in an 
intensive production system 
Klinkenberg et al., 2002 [12] 
7.77 (4.68–12.9) Weaner pigs between-pen estimate in 
an intensive production system 
Klinkenberg et al., 2002 [12] 
15.5 (6.20–38.7) Slaughter pigs within-pen estimate Klinkenberg et al., 2002 [12] 
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3.39 (1.54–7.45) Slaughter pigs between-pen estimate Klinkenberg et al., 2002 [12] 
13.7  Experimental pigs in a pen Laevens et al., 2013 [13] 
13.0 Gilts in a pen Dewulf et al., 2001 




From Table 2 it is evident that the distance between infected and susceptible pigs, the contact rate, dose 
received and host factors influence the rate of transmission. At the population level, direct contact can be 
significant risk for the transmission of CSFV.  During the high-risk period of the Dutch outbreak in 1997-1998, 
17% of the between-herd virus spread was due to direct contact [10].  In addition, eating raw pork meat is a 
common cultural practice in tribal areas of some Southeast Asian countries, permitting uneaten waste meat to 
become available for domestic as well as wild pigs to feed upon. A summary of risk factors for the introduction 
and spread of CSFV has been compiled by the OIE, and is presented in Table 3 [14]. 
The main risks for transmission of CSFV include the movement of pigs, which are incubating the disease, or are 
persistently infected; indirect spread of virus through transport vehicles; human contacts; and feeding pork 
waste, which has not been properly heated. Classical swine fever virus can survive in pork and pork products 
after processing [14]. The presence of virus in infected wild boar is an important risk factor either through direct 
live contact or indirect contact, including feeding infected uncooked meat to susceptible pigs.  Mechanical 
transmission over short distances (neighborhood effect) by wind aerosols, arthropod vectors, birds, pet animals 
and rodents has sometimes been reported as well as transmission by manure and by contaminated semen 
through artificial insemination practices [14].  
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The CSFV is categorized into three major genotypes containing 10 sub-genotypes as defined by the E2-gp gene 
fragment depicted in Figure 4 [15]. 
Interestingly, the only African CSFV isolate detected in South Africa belongs to Group 2.1, and is related to 
isolates from Asia and Europe.  The molecular epidemiology of this lone African isolate suggests an 
epidemiological link related to trade with these other regions.  In addition, the evolution of Group 3 is clustered 
in the Asian region thus far.  Phylogenetic analysis of the Korean field isolates of 1988 - 1999 fall under subgroup 
3.2, however the viruses isolated during the 2002-2003 CSF epidemics belong to a different group [16]. Beer et al. 
have summarized the global spatial distribution of CSFV sub-genotypes as presented in Figure 5 [17]. CSFV isolates 
from Asia were also classified by Geiser-Wilke and Paton, which are summarized in Table 4 [18]. 
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Figure 5: Global spatial distribution of CSFV sub-genotypes 
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Country Epidemiological Relevance Reference 
1.1 Hokkaido, Japan 1996 isolate [18] 
2.3  Osaka, Japan 1971 isolate [18] 
1.1 Thailand 1980’s Lowings et al. 1996: Parchariyanon et al. 2000  
1.2 Thailand and 
Malyasia 
1980’s Lowings et al. 1996: Parchariyanon et al. 2000  
2.1 Austria Wild boar meat imported into 
Austria from China  
Hofrilann and Bossy 1998  
 
2.2 Thailand 1990’s [18] 
1.3 Thailand and 
Malaysia 
New cluster developed from 





Korea 1980’s and 1990’s [18] 
3.3 Thailand 1990’s [18] 




Viet Nam has the largest pig population in Southeast Asia where 70% of the 27.4 million pigs (2010) are raised in 
smallholder production units [19].  In Viet Nam, Tung et al. conducted a study on 44 CSFV isolates from the 
country along with 271 reference viruses and found that a single sub-genotype 2.1c of CSF virus was dominant in 
the north Vietnam in 2010, while Dung, et al. had reported the presence of both sub-genotype 2.1 (8 isolates) 
and 2.2 (10 isolates) in the same region in 2003 [20]. In the neighboring Lao People’s Democratic Republic (PDR), 
genotype 2.1 is found in the north-central region while genotype 2.2 is found in the south-central region [21].  
Figure 6 presents a map of the locations for these two genotypes in Lao PDR. 
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CSFV is also a significant disease in South Asia where molecular research is being actively pursued.  The 




Figure 6: Map of Lao PDR depicting the locations of CSFV genotypes 2.1. And 2.2 
 




Indian State/Country Epidemiological Relevance Reference 
1.1 Uttar Pradesh Immunogenic vaccine seed strain Singh et al. 2006 
Strain Shimen- 
HVRI  
Mizoram State Related to isolates from Myanmar and 
China 
Barman et al., 2010 
2.1 Survey of various 
Indian States  
Related to European strain Desai et al., 2010 
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1.1 Assam 190 isolates from field outbreaks 
characterized using E2 gene fragment 
Patil et al., 2011 
2.1 Assam  Ahuja, 2015 
2.2 Karnataka Analysis of NTR gene region Chakraborty et al., 2011 
2.2 Uttarakhand First whole genome sequence of 2.2 in 
India 
Kumar et al., 2014 
2.2 Nepal Part of endemic cycle and closely matches 
Indian CSFV isolates 




Lowings et al. assessed the evolution of CSFV sub-genotypes to occur at a rate of 1-9 x 10-3 to 9.3 x 10-3 
substitutions per base per year [22].  Another study used the Bayesian statistical analysis to study the evolution of 
the NS4B gene fragment of 37 isolates and determined an evolutionary rate of 13 × .010-4 substitutions per site 




Wild boar in Europe play a role as reservoirs but not in the classic sense since transmission among European wild 
boar is very limited. However the European wild boar remains an important source for domesticated pigs in 
Europe [11].  Limited epidemiological data currently exists regarding the role of wild and feral pigs in Asia. 
Virus-host interaction is critical in order to understand the epidemiology of CSFV in pig populations.  
Experimental studies using a single commercial genetic line of pigs demonstrates that the virulence of CSFV 
isolates is highly variable and young pigs are more susceptible to CSFV.  For CSF, the clinical and pathological 
scoring criteria is based on case fatality rate, antibody production and leukocyte count [24]. A molecular genomic 
study of 52 isolates found that CSFV virulence could not be linked to any particular genome sequence [25]. Most 
of the highly virulent CSFV strains belong to genotype 1 which also includes the vaccine strains. Moderately 
virulent strains belong to genotypes 2 and 3. There is evidence that genetic variability within the genotype 1 is 
lower compared to strains of genotype 2 and 3. The study presents the hypothesis that sequence signatures of 
virulence may be found using the full sequence data of vaccine strains and parental highly virulent strains [25].  
However, from the functional point of view, virulence may depend on viral replication efficiency, which can be 
influenced by differences in protein expression and other host-agent interactions.  
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Genetic differences with the pig population influence the transmission and temporal dynamics of CSFV 
outbreaks.  Blacksell et al., investigated in Lao PDR the susceptibility of indigenous Moo Laat (ML) and improved 
Large White/Landrace cross (LWC) pig breeds to infection with CSFV under controlled conditions [26].  This study 
generated a survival analysis of both breeds as shown in Figure 7. The following conclusions from this study 
indicate that: 
• Native breed and an improved pig breed are fully susceptible to CSFV infection and the mortality rate is 
high.  
• LWC pigs demonstrated lower (or shorter) survival times (50% survival time: 11 days), earlier and higher 
pyrexia and earlier onset of viraemia compared to ML pigs (50% survival time: 18 days).  
• In the context of village-based pig production, the longer time from infection to death in native ML pigs 
means that incubating or early sick pigs may increase and prolong transmission of CSFV since they are 
likely to be sold once an outbreak of CSF is recognized in a village.  
• This increased longevity probably contributes to the maintenance and spread of disease within a 





Figure 7: Survival characteristics of CSFV in Moo Laat and Large White/Landrace cross breeds from Lao PDR 
 
Virus excretion for mild moderate and highly virulent strains differ.  Weesendorp et al., conducted a study to 
measure the excretion of CSFV over time from pigs infected with a high, moderate or low virulence strain. The 
study measured clinical signs, conducted RT-PCR analysis as well as virus titration from conjunctival fluid, nasal 
fluid, faces and urine for 56dpi.  The study highlights the crucial role chronically infected pigs play in the 
transmission of CSFV as summarized below [27]: 
Classical Swine Fever | Monograph 07 






1. Infectious virus was excreted in all secretions and excretions of pigs infected with the highly and 
moderately virulent strain, while excretion from pigs infected with the low virulent strain was mostly 
restricted to the oronasal route;  
2. Pigs infected with the highly virulent strain excreted significantly more virus in all their secretions and 
excretions over the entire infectious period compared to pigs infected with the moderately or low 
virulent strains. However this prolonged high level shedding did not occur in the pigs that developed the 
chronic form of infection after inoculation with the moderate virulence strain;  
3. During the entire infectious period, infected pigs excreted the largest amounts of virus via most 
secretions and excretions, as they excreted virus continuously and for a long duration.  
Congenital infection through transplacental infection from a carrier sow is another critically important 
mechanism for the persistence and transmission of CSFV.  The infected foetus can die in utero, in the neonatal 
period, or it may be born with teratogenic defects. In addition, apparently healthy progeny can develop a late 
onset disease, months, or years after birth, or remain clinically normal for life. The outcome of a congenital 
infection is mainly determined by the stage of fetal development at which the infection occurs [28].   If the 
infection occurs during the first trimester, before the fetuses have developed immune competence, it can result 
in the birth of persistently infected piglets. These piglets are born asymptomatic and without antibodies to CSFV. 
They then shed virus intermittently until they develop clinical signs of acute CSF and die up to 11 months later 
[29].  
The ability of two CSFV field isolates of low and moderate virulence to induce viral persistence after early 
postnatal infection has been evaluated [30].  Two litters of 10 piglets each were infected intranasally on the day of 
birth with low and moderate virulence CSFV isolates, respectively. During the six weeks after postnatal infection, 
most of the piglets remained clinically healthy, despite persistent high virus titers in the serum. Importantly, 
these animals were unable to mount any detectable humoral and cellular immune response. At necropsy, the 
most prominent gross pathological lesion was severe thymus atrophy.  
Finally, Figure 8 summarizes the epidemiological features for the transmission of CSFV from piglets infected 
during the neonatal period either acutely or chronically [15].   Note that virus shedding is prolonged and antibody 
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Figure 8: Model experiments for acute and chronic from postnatal infections in piglets 
Environmental Factors 
Weesendorp et al. conducted a study to quantify aerosol spread of CSFV under experimental housing conditions 
[31].  They used highly virulent strains with titers of 101.2 to 103.0 TCID50/m3 of infectious virus and 101.6 to 103.8 
TCID50 equivalents/m3 of viral RNA. They observed that the higher the dose used for inoculation of the pigs, the 
sooner virus could be detected in the air samples. There is also a moderate relationship between infectious virus 
titer in the air and the number of pigs excreting infectious virus in faeces (Spearman’s rank correlation 
coefficient 0.67, p=0.005) or oropharyngeal fluid (Spearman’s rank correlation coefficient 0.57, p=0.014).  No 
infectious virus or viral RNA was detected with the low virulence strain, indicating that the level of aerosols 
released corresponds to the virulence levels of CSFV. 
The ecological carrying capacity, food availability across the interface between the wild and feral pigs with the 
domesticated pigs in the smallholder village setting also affects the rate of contact and likelihood of introduction 
and transmission in the population [11].  Human behaviour such as hunting feral and wild pigs and feeding their 
uncooked parts to domestic pigs is also a risk at the interface noted above.   
Clinical Signs 
The clinical signs of CSFV are not pathognomonic and are based on whether the infection with CSFV is the acute 
form, the chronic form or the congenital form.  The precise signs and symptoms will also vary due to the host 
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characteristics (genetics, age, previous exposure) including the virulence of the specific CSFV involved.  Based on 
the OIE definitions, the clinical signs associated with CSFV in pigs are summarized in Table 6 [3][4]. 
 
Table 6: Clinical signs consistent with the four forms of CSFV 
 
Acute Chronic Congenital Mild 
Virulence 
Virulent virus strains 
and/or younger pigs   
Less virulent virus strains 
or partially immune herds 
  
Depends on virulence of 
virus strain and stage of 
gestation   
Mild in older pigs 
Mortality 
Mortality in young pigs can 
approach 100%   
Moderate Variable up to 100% Low 
Time until death 
5–25 days after onset of 
illness   
Apparent recovery with 
eventual relapse and death 
in 3 months   
Within weeks or up to 12 
months  
 
Long time period 
Clinical signs 
• Fever (41°C)  
• Anorexia, lethargy  
• Severe leucopenia  
• Multifocal hyperaemia 
and/or haemorrhagic 
lesions of the skin 
• Conjunctivitis  
• Enlarged, swollen 
lymph nodes  
• Cyanosis of the skin 
especially of 
extremities (ears, 
limbs, tail, snout)  
• Dullness, capricious 
appetite, pyrexia, 
diarrhoea for up to 1 
month  
• Ruffled appearance of 
pigs  
• Growth retardation  




• Abortion  
• Congenital tremor, 
weakness 
• Runting and poor 
growth over a period 
of weeks or months  
• Transient pyrexia and 
inappetence  
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• Transient constipation 
followed by diarrhoea  
• Vomiting (occasional)  
• Dyspnoea, coughing  
• Ataxia, paresis and 
convulsion  
• Pigs huddle together  
Epidemiological significance 
Rapid short term onset, 
virus multiplication and 
transmission in single age 






Born clinically normal but 
persistently viraemic with 
no antibody response: 
important intermittent 
shedders of virus  







The OIE advises that “A tentative diagnosis based on clinical signs and post-mortem lesions must therefore be 
confirmed by laboratory investigations. As pyrexia is one of the first signs of CSF and is accompanied by viraemia 
(Depner et al., 1994), detection of virus or viral nucleic acid in whole blood, collected in heparin or ethylene 
diamine tetra-acetic acid (EDTA), or in tissues, collected from febrile animals, is the method of choice for 
detecting infected herds at an early stage.” [3] 
 
Laboratory methods for diagnosis of CSF are aimed at detection of: 1) the virus; 2) viral nucleic acid or viral 
antigens; or 3) detection of specific antibodies. Targeted and risk-based sampling of animals is recommended as 
follows [2]: 
• When no clinical signs of disease are present: random sampling is applied;  
• When diseased animals and febrile animals are present:  Detection of virus, viral antigen or nucleic acid;  
• To verify previous exposure: Detection of antibodies from animals that have recovered from disease or 
animals that have been in contact with infected or diseased animals persist for life [4]. 
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There are two challenges in the diagnosis of CSFV.  Firstly, the clinical signs of classical swine fever are similar to 
a number of other swine diseases.  Secondly, the diagnostic tests used must be able to differentiate CSFV from 
bovine viral diarrhea (BVD) and other pestiviruses. 
The differential diagnosis of CSFV considered will vary depending on the form of the CSF disease, including 
acute, chronic, congenital (and mild forms).  It is therefore essential to send samples for laboratory 
confirmation.  Important categories of clinical symptoms for other diseases, which may resemble the various 
forms of classical swine fever, are summarized in Table 7 [4]: 
 
Table 7: Differential diagnosis of CSF 
 
African swine fever: A primary differential diagnosis to rule out with indistinguishable clinical signs and pathological 
lesions;  
Septicaemias with skin lesions: erysipelas, eperythrozoonosis, salmonellosis, streptococcosis, pasteurellosis, 
actinobacillosis, and Haemophilus parasuis;  
Haemorrhage: porcine dermatitis and nephropathy syndrome, haemolytic disease of the newborn, coumarin 
poisoning, thrombocytopenic purpura; 
Runting: post weaning multisystemic wasting syndrome, enterotoxicosis, swine dysentery and campylobacteriosis;  
Abortion: Aujeszky’s disease (pseudorabies virus), encephalomyocarditis virus infection, porcine reproductive and 
respiratory syndrome, parvovirus;  
Nervous signs: viral encephalomyelitis, salt poisoning;  




Gross pathology or gross lesion at post-mortem 
Gross post mortem lesions associated with CSFV are not pathognomonic.  Lesions in the following organ systems 
must be further investigated with laboratory tests when they are found.  Table 8 presents a summary of gross 
pathological changes associated with the three main forms of ASF disease resulting in pathological lesions. 
 
Classical Swine Fever | Monograph 07 






Table 8: Gross pathological changes associated with the four forms of ASF disease 
 
Body system Acute form Chronic form Congenital form 
Haematopoietic Leucopoenia and 
thrombocytopenia; 
Multifocal infarction of the 
margin of the spleen  
  
Integumentary Petechiael and ecchymotic 
haemorrhages  
  
Nervous Encephalomyelitis with 
perivascular cuffing is 
common  
 Central dysmyelinogenesis, 
cerebellar hypoplasia, 
microencephaly,  
Digestive Petechiael and ecchymotic 
haemorrhages 
Button’ ulcers in the 
caecum and large intestine 
mucosa  
 
Renal Petechiael and ecchymotic 
haemorrhages 
  
Respiratory Lungs may be congested 
and haemorrhagic  
 Pulmonary hypoplasia  
 
Lymphatic Enlarged haemorrhagic 
lymph nodes are common; 
Severe tonsillitis with 
necrotic foci  
Generalized depletion of 
lymphoid tissue  
 
 
Reproductive    
Musculo-skeletal  Transverse striations of 
unmodelled growth 
cartilage at costochondral 
junctions in growing pigs  
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The method of choice for detecting herds early in infection is to collect whole blood and tissues from febrile or 
recently dead animals.  Recommended tissues to collect include tonsil, lymph nodes (pharyngeal, mesenteric), 
spleen, kidney, distal ileum, blood in EDTA or in Heparin tubes (live cases).  The OIE specifies the following tests 
for the detection and confirmation of CSFV [3]: 
 
Identification of the agent:  
1. VI: The definitive test  
In the laboratory, CSFV from organs, leukocytes or whole blood is cultured in the PK-15  cell line (porcine 
kidney).  Presence of the CSFV does not generally cause a visible cytopathic effect [1].  The presence of CSFV must 
be demonstrated by an immunostaining method, which may be carried out after one or two virus passages. This 
can be done by examining the cultures for fluorescent foci by the FAT after 24–72 hours or by 
immunoperoxidase staining after 3–4 days of incubation. The specific test protocols are provided for the 
following matrices: 
a. Protocol 1: Tissue samples from dead pigs; 
b. Protocol 2: Whole blood from sick pigs (less sensitive but earlier detection possible from clinical 
cases); 
c. Protocol 3: Two passages in PK-15 cells will increase sensitivity to detect CSFV in both organ and 
blood samples. 
d. Protocol 4: RT-PCR provides results quickly with high sensitivity; 
e. Protocol 5: CSFV RNA followed by nucleotide sequencing permits the study of the molecular 
epidemiology of CSFV following RT-PCR.  
2. Immunological methods: Provide presumptive but requires confirmation by virus isolation or RT-PCR 
when negative results are obtained. 
a. FAT of tissue samples.  RT-PCR is required to differentiate infected from vaccinated pigs; 
b. Immunoperoxidase procedure for differentiation of pestiviruses by monoclonal antibodies and 
for the differentiation of infected from vaccinated pigs.  Figure 9 presents the systematic 
approach for interpretation of the Immunoperoxidase procedure for CSFV noted above. 
c. Antigen-capture assay for rapid diagnosis of CSF in live pigs, antigen-capture ELISAs have been 
developed for screening herds suspected of having been recently infected.  
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In addition, Aguerro et al. have developed a highly sensitive and specific one-step hot start multiplex RT-PCR 
assay for the simultaneous and differential diagnosis of African swine fever virus (ASF) and CSFV [32].  Universal 
detection of ASF and CSF virus strains was achieved through selection of primers in conserved viral genome 
regions through a study of 150 positive field samples from several ASF and CSF outbreaks validated the 
suitability of this method for a rapid, sensitive and specific differential diagnosis in clinical samples.  
 





Serological tests:  
Due to the immunosuppressive effect of CSFV, antibodies cannot be detected with certainty until at least 21 dpi. 
The following tests are applied: 
1. NPLA is a prescribed test for international trade; 
2. FAVN is a prescribed test for international trade; 
3. ELISA is a prescribed test for international trade. 
The OIE official diagnostic test methods for the diagnosis of classical swine fever and their purpose are 




Classical swine fever virus is species-specific for pigs and is not considered to be a zoonotic disease [1][3][4]. 
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Regionally, the most active areas of reported CSFV events during the first six months of 2015 were Southeast 
Asia and South Asia including Nepal.  The lack of reporting from India is likely due to late reporting since: i) Nepal 
is affected and cross border trading is ongoing with India; and ii) reports since 2000 consistently show a 
significant number of reported cases (see incidence Table 12 below).  The OIE map of reported CSFV globally is 






Figure 9: OIE map of reported CSFV 
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Figure 10: Global status of CSFV Free Countries as of May 2015 
 
However, uncertainty remains with respect to the status of CSFV in Africa.  Table 11 summarizes the reporting 
status of CSFV in the 14 African countries included in the 20 selected countries of the Livestock Vaccine 
Innovation Fund (LVIF) [33].  
 
Table 11: Ten leading disease losses globally by livestock disease units (LSU) loss 
 
Country Status Reference 
Burkina Faso  Disease never reported OIE, 2009  
Côte d'Ivoire  Disease not reported OIE Handistatus, 2005  
Ethiopia  No information available OIE, 2009  
Kenya  Disease never reported OIE, 2009  
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Madagascar  Present OIE, 2009  
Malawi  Disease never reported OIE, 2009  
Mali  No information available OIE, 2009  
Mozambique Disease never reported OIE, 2009  
Rwanda  No information available OIE, 2009  
Senegal  Disease never reported OIE, 2009  
South Africa  Disease not reported OIE, 2009  
Tanzania  Disease never reported OIE, 2009  
Uganda  No information available OIE, 2009  




Madagascar became infected with CSF by the introduction of infected pigs from Europe in 1965 and the disease 
has been endemic ever since [34]. South Africa was affected by CSF between 2004 and 2007 when it was 
eradicated through a challenging culling campaign of a half million pigs.  The South African outbreak was linked 
to food waste from a ship traveling from Asia and not to neighbouring countries.  Experimental evidence 
supports the hypothesis that bush pigs were severely affected and died rapidly and so would be unlikely to 
become a reservoir host.  However warthogs were less severely affected, with non-specific clinical signs and 
pathological lesions and could potentially act as a reservoir host [34]. 
A summary of the incidence of CSFV and the prevalence of CSFV between 2000 and 2015 in the 20 selected 
countries of the LVIF is presented in Table 12 and Table 13, respectively. 
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Incidence of CSFV in 20 Selected Countries 
  
Table 12: Annual incidence of CSFV in 20 selected countries, 2000 to 2015. 
 
Region/Country 
Reported Incidence CSF (OIE, WAHID)  
http://www.oie.int/wahis_2/public/wahid.php/Diseaseinformation/statusdetail# (Accessed 21/10/2015) 
 
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 
Sub Saharan Africa                 
Burkina Faso 0 0 0 0 0 … 0 0 0 0 0 0 0 0 0 … 
Ethiopia 0 0 0 0 0 … … … … 0 0 ? ? 0 0 … 
Ivory Coast 0 0 0 0 0 0 … … 0 0 0 0 0 0 0 0… 
Kenya 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0… 
Madagascar 3 … 27 16 17 5 6 ...+ ...+ ...+ 7 2 2 4 4 … 
Malawi 0 0 0 0 0 0 0 0 0 0 0 0 0 0 … … 
Mali 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 … 
Mozambique 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 … 
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Rwanda … … … … 0 … 0 0 0 0 0 0 0 0 0 … 
Senegal 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0… 
South Africa 0 0 0 0 0 68 22 1 0 0 0 0 0 0 0 0… 
Tanzania 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0… 
Uganda 0 0 0 0 0 0 … … … … … … … … … … 
Zambia 0 0 0 0 0 … 0 0 0 0 0 0 0 0 0 … 
South Asia                 
Bangladesh … 0 0 0 0 … … 0 0 0 0 0 0 0 … … 
India 5 236 190 53 59 54 40 93 95 136 418 284 252 117^ 69 … 
Nepal 5 12 31 15 6 19 23 30 8+ 29 14 34 10 6 9 2… 
Southeast Asia                 
Indonesia … … … … … … ...+ ...+ ...+ ...+ ...+ ...+ ...+ ...+ … … 
Myanmar 4 10 0 1 2 …+ 2+ 1…+ 3 0 0 0^ 0 2 3 … 
Vietnam … … … 58 … 221 364 337 650 171 214 68 128 80 65 24… 
Legend: ^PRRS First Reported 
 
WAHIS Codes 2005-2015 
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... No information available for this disease 
0 Disease absent 
...+ Disease present but without quantitative data  
 
HandiStatus II Codes 2000-2004: 
... No information available 
0 Disease absent 
 
 
Prevalence in 20 Selected Countries 
Table 13: Prevalence estimates for CSFV in 20 selected countries based on the available peer-reviewed studies 
 
Region/Country Apparent Prevalence (CI) Study Design Time Period Reference 
Sub Saharan Africa 
    
Burkina Faso 
    
Ethiopia 
    
Ivory Coast 
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Madagascar 
    
Malawi 
    
Mali 
    
Mozambique 
    
Rwanda 
    
Senegal 
    
South Africa Serological surveys in domestic 
pigs and a limited number of 
warthogs sampled have yielded 
no positive samples since 
October 2007 and national 
surveillance gave no indication 
of spread to other provinces. 
Prospective serological 
surveys in the Eastern 
Cape 
2007-2010 Akol and Lubisi ,2010 
Tanzania 
    
Uganda 
    
Zambia 
    
South Asia 
    
Bangladesh 
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India Seroprevalence was 41% 
(89/218) and prevalence of CSFV 
antigen in blood samples was 
32% (39/121) for the 10 districts 
of Karnataka. Seroprevalence of 
61%, 29%, 20%, and 21%; and 
antigen prevalence of 40%, 50%, 
13%, and 12% were recorded for 
Bangalore, Mysore, Belgaum, 
and Gulbarga divisions of 
Karnataka, respectively. 
Prospective serological and 
antigen capture ELISA 
based survey in selected 
districts and divisions of 
Karnataka State 
2013-2014 Choori et al., 2015 
 
CSF seroprevalence of 63% from 
12 different states of India 
during 2004-2010 and 53% 




2004-2010 Nandi et al., 2011 
 
Seroprevalence of CSF in Kerala 
and Tamil Nadu to be 
approximately 77% (31/40) and 
100% (10/10), respectively 
Prospective serological 
survey  
2012-2013 PD_ADMAS. 2013 
 
The prevalence of CSF 
antibodies from serum samples 
for the whole of Karnataka was 
33% (173/517) in 20 districts 
Prospective serological 
survey  
2014 Shivaraj et al., 2014 
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Nepal Out of 233 outbreaks since 
2002, 143 (61.37%) and 90 
(38.6%) were reported from hill 
and terai (lowland) regions, 
respectively. None reported 
from the mountain region. 
Geographic distribution of 
CSFV outbreaks in Nepal 
2002-2014 Proceedings of 1st National 
Workshop on Pig and Pork 
Industry in Nepal, 2014 
Southeast Asia 
    
Indonesia 17.8% (95% CI: 15.1-20.8%) of 
the pigs were seropositive to 
CSF. 
Prospective serological 
survey involving 720 pigs 
2010 Bulu, 2011 
 
30.9% seropositive Prospective serological 
survey  
NA Santhia et al. 2001  
 
seroprevalence was estimated 
at 17.5% (lower CI 16.0%; upper 
CI 19.5%). 
Cross-sectional 
seroprevalence survey was 
conducted in 2010 
involving 2,160 pigs and 
805 farmers from four 
islands in the region. 
2010 Sawford et al., 2015 
Myanmar 
    
Vietnam All 10 farms with mortality were 
positive by RT-PCR test; 
Antibody against CSF virus was 
not detected in 7 of 10 herds 
during an outbreak of CSF.  
Cross-sectional study 
during an active outbreak 
in Cantho Province 
2002-2003 Kamakawa et al. 
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There were a total of 4,938 CSFV events reported by the 20 selected countries investigated by the LVIF between 
2000 and 2015.  Forty-eight per cent (48%) of all CSFV events were reported in Viet Nam while 42% were 
reported in India.  Nepal (5%), Madagascar (2%), South Africa (2%) and Myanmar (1%) accounted for the 
remainder of reported events during the same time interval.  Figure 11 provides an ordered ranking by number 




Figure 11: Total number of CSFV Events Reported Among Selected Countries, 2000-2015 
The maximum number of 748 CSFV events was reported in 2008 among the 20 selected countries, 2000-2015.  
Figure 12 presents a graph of the temporal distribution of CSFV events in the 20 selected countries from 2000 to 
2015. Among SE Asian countries, incidence of CSF is considered to be higher in Indonesia (despite under-
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Figure 12: Temporal distribution of CSFV events in the 20 selected countries from 2000 to 2015 
In Lao PDR, considerable research on CSFV has been conducted with support from the Australian Animal Health 
Laboratory (AAHL), Geelong.  In 1998, a laboratory project received 257 samples. Fifty were CSFV antigen 
positive representing 35 outbreaks (I9.5 %of the total samples submitted). In 1999, 87 samples were received 
with 19 positive samples from 11 outbreaks (21.8 %) [35].   Other additional detailed prevalence estimates at the 
provincial level in Lao PDR are summarized in Figure 13 [36]. 
 













Khounsy and Conlon, 2008 
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Number of CSFV Events by Year in 20 Selected Countries, 2000-
2015
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Economic and Social Impacts at Global 







Losses of animals of different species are calculated as Livestock Unit (LSU) losses, using the definitions 




Figure 14:  
 
Classical swine fever ranks as the most economically significant disease of pigs globally.  An epidemic of CSF, 
which occurred in the Netherlands in 1997-98, led to the death or slaughter of approximately 12 million pigs as 
part of the eradication campaign. The cost of this outbreak was estimated to be US$2.5-3 billion [36].  Some 
general economic impacts of CSF with references are summarized in Table 14. 
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Table 14: General economic impacts published for CSF disease 
 
Economic Impact of CSF Reference 
The largest direct economic impact of CSF is through 
reduced production; Morbidity and mortality directly 
impact upon the farmers’ financial viability and can also 
influence the market price of pork 
Rendleman and Spinelli, 1999 
Impact depends upon the response strategies adopted by 
farmers and any possible market effects. The impact can 
be mitigated if the farmers’ income source is diversified or 
if there are other opportunities to generate income 
Le Gall, 2006 
National pig restructuring plan in the Netherlands resulted 
in a reduction of the national pig herd by approximately 
25% within two years 
FAO, 2002 
Bans on the export of products and subsequently may 
impact upon the market price of pigs  
Bech-Nielsen et al., 1993 
Of three control strategies in free areas (detecting and 
stamping-out affected herds; strategies not based on 
vaccination; and emergency vaccination), not adopting 
vaccination can minimize the costs for controlling the 
disease  
Saatkamp et al. 2000 
In extensive pig-holding systems in developing countries 





CSF accounts for the highest pig losses measured in livestock units lost globally.  Figure 15 presents a summary 
of the ranking of pig diseases in terms of Livestock Units (LSU) lost, 2006-2009 [37]. 
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Figure 15:  
 
Figure 16 further summarizes the geographic distribution of the top 10 countries impacted through LSU losses 
due to CSFV, 2006-2009. In descending order South Africa, Viet Nam and India rank among the most affected 
among the selected countries [37].  
Asia is the largest producer of pork in the world accounting for 56% of global pork production (109,216 thousand 
tones), with China accounting for 48% of the global pork production [38].  The countries within the ASEAN have a 
combined 68 million pigs or 7% of the global total of 968.16 million based on 2010-2013 and 2011 estimates, 
respectively [19]. Table 15 summarizes the population size, production system and trade value for eight ASEAN 
countries including Indonesia and Viet Nam. 
Similar details are not available for the member countries of the SAARC, however the International Livestock 
Research Institute (ILRI) has projected the economic impact of CSFV in Northeast States of India, presented in 
Table 16 (http://asia.ilri.org/2014/02/04/csf-india/). 
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Figure 16:  Geographic distribution of the top 10 countries impacted through lost LSU due to CSFV, 2006-
2009 with b): expanded view of Asian distribution 
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Table 16: Profile of the pig populations of eight ASEAN countries, production systems and trade values 
 
 Assam  Mizoram  Nagaland  Total  
Cost of mortality (US$)  30 million  0.51 million  4.04 million  34.55 million  
Cost of treatment (US$) 0.364 million  6,646  60  0.371 million  
Cost of replacement (US$) 1.542 million  29,152  0.271 million  1.842 million  
Total costs (US$) 28.715 million  0.549 million  4.366 million   33.63 million  
TOTAL US$    70.393 million 
 
 
Table 17 summarizes the data related to the socioeconomic impacts of CSFV in the 20 selected countries under 
the LVIF.
Joint FAO/OIE Workshop on Swine Disease Control in Asia
Basic information
ASEAN PIG INDUSTRY
Country Population/Year Type of 
Operation
Trade/Value
Vietnam 27.4 M/ 2010 70% backyard domestic/US$60 M
Philippines 11.98 M/ 2014 July commercial 31%, 69 
%backyard
domestic/US$3.66 B




Indonesia 8.25M/ 2013 small, medium,
commercial scales
Export/US$$10.34 M
Malaysia 1.39M/  2013 large scale US$479.00 M
Myanmar 4.49 M/ 2012 75% backyard domestic
Lao PDR 2.46 M/ 2008 70% backyard domestic
Cambodia 2.4M/ 2013 small scale, 
subsistence
domestic
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Table 17: Socioeconomic impacts of CSFV based on peer-reviewed publications in 20 selected countries 
 
Region/Country Economic Impact Social Impact Year Reference 
Sub Saharan Africa 
    
Burkina Faso 
    
Ethiopia 
    
Ivory Coast 
    
Kenya 
    
Madagascar 
    
Malawi 
    
Mali 
    
Mozambique 
    
Rwanda 
    
Senegal 
    
South Africa The outbreak of CSF in the Eastern Cape, 
2004-2007 was the largest pig disease 
outbreak that South Africa had ever 
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the outbreak in the Eastern Cape are 
informally reported to have been 
devastating).  
 
The South African government paid more 
than US$13.1 million (R200 million) to 
compensate the more than 83 000 affected 
farmers; the compensation paid per pig was 
US$130; The culling of pigs affected pork 
availability, income generation and caused 
ecosystem disturbance in the crop-livestock 
communal production systems. 
22% of the farmers were resisting culling 
insisting that they were an important part 
of their livelihoods. Most people (92%) 
mentioned that they were infuriated seeing 
government officials going around killing 
pigs; government’s delays in compensating 
farmers may further explain the hiding of 
pigs by some farmers. According to the 
Department of Agriculture (2006);  
2007  (National African 
Farmers Union (NAFU), 
2007). 
Tanzania 
    
Uganda 
    
Zambia 
    
South Asia 
    
Bangladesh 
    
India CSF incurs direct costs to farmers, mainly as 
stock morbidity, cash treatment costs, and 
replacement cost of dead animals and overall 
loss of livelihood. Veterinary authorities incur 
costs associated with preventing the disease 
 
2014 ILRI, 2014 
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and managing outbreaks, while national 
economies are impacted through restrictions 
on trade opportunities. 
 Pig farmers in India incur huge losses from 
mortality, treatment and replacement costs—
over US$30.3 million each year  
 2012 ILRI, 2012 
Nepal 
    
Southeast Asia 
    
Indonesia 300,000 to 400,000 pig mortalities from a 
total population of approximately one million 
pigs were reported in Bali alone 
 
1995 Bulu, 2011 
Myanmar Risk of CSFV from neighboring Indian State of 
Mizoram 
 
2014 ILRI, 2914 
 
Mizoram bans import of pigs from Myanmar 
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Vietnam Classical Swine Fever (CSF) and Newcastle 
disease (ND) are endemic and serious threats 
to small-scale producers, while FMD is a 
major threat to the emerging intensive dairy 
sector. Overall, CSF and ND are probably of 
greater economic relevance than FMD, 
although the latter has most attention; Foot 
and Mouth Disease and Classical Swine Fever 
are more important barriers to global market 
access, in particular to the main OECD 
countries markets. 
 
2006 Vietnam Food Safety and 
Agricultural Health 
Action Plan, 2006 
 
Losses per pig due to CSF range from US$23 
to US$ 28 in Viet Nam; at the household level, 
this amounts to between US$53 and US$295; 
the highest losses in households that raise 
and fatten pigs (multi-age holdings) 
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Sanitary measures for the Control of CSF during outbreaks, with particular emphasis on the smallholder pig 
production system are listed below [4][19][40][41][42][43]: 
• Policy for culling if feasible; 
• Slaughter of all pigs on affected farms;  
• Safe disposal of carcasses, bedding, manure and contaminated waste;  
• Thorough cleaning and disinfection;  
• Designation of infected zone, with inter-jurisdictional control of pig movements; 
• Detailed epidemiological investigation, with both up-stream tracing of possible sources and down-
stream tracing for possible spread of infection;  
• Surveillance of infected zone, and surrounding area;  
• EU measures in the case of a CSF outbreak: depopulation of infected herds, surveillance and movement 
restriction in the 3 and 10 km zones and surveillance in herds that have been in contact with infected 
herds plus depopulation of contact herds [40]; 
• In a region with a low farm density, the basic EU measures are sufficient to control an epidemic. In a 
region with a high farm density, depopulation of contact herds would not be necessary [41].  
• Reducing the number of animal movements significantly reduces the size and length of epidemics in 
areas with high pig density [42].  
• Early detection of CSFV is critical.  A recent experimental study demonstrated that the nictitating 
membrane (third eyelid) provides a useful source of virus in pigs which have undergone autolysis, since 
it is much less affected by autolysis than the internal organs [34]; 
• Emergency vaccination in addition to eradication can reduce control costs provided that the vaccinated 
animals can be sold for commercial slaughter and not culled [42];  
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• The modified live vaccine for CSF would be the vaccine of choice, since immunity develops rapidly [43]. 
Although preferable, the use of a marker vaccine is not essential for emergency vaccination, provided 
vaccinated animals are clearly identified by some other means such as ear tags or tattoos [42].  
 
Medical Measures 
No medical treatment exists for CSFV and so virus source reduction through effective and humane culling and 





The following sanitary prophylactic measures have been recommended [4][44]: 
• Education, awareness raising and on going communication between veterinary authorities, veterinary 
practitioners, traders and pig farmers;  
• Effective disease reporting system;  
• Strict import policy for live pigs, pig semen, and fresh and cured pig meat;  
• Quarantine of new pigs being admitted into the herd; 
• Efficient cooking or prohibition of waste food fed to pigs;  
• Effective biosecurity plan for rendering plants, personnel;   
• Structured serological surveillance targeted to breeding sows and boars;  
• Effective pig identification and recording system for tracing; 
• Effective hygiene measures protecting domestic pigs from contact with wild boar and feral pigs; 
• Zoning and compartmentalization based on formal risk assessments [44]. 
 
Medical Measures 
The following medical prevention measures should be contextually relevant and based on OIE recommendations 
and peer-reviewed studies [4][39][43]: 
• Enzootic countries:  Vaccination with modified live virus strains is effective in minimizing losses but it 
cannot eliminate infection; 
• Countries free of CSF, or in the process of eradicating CSFV:  Culling and eradication is practiced while 
vaccination is normally prohibited [4][39]; 
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• In the highly endemic areas in Southeast Asia: Routine vaccination against CSF is the most common 
means used for prevention and control. However, the increased incidence of chronic CSF during the 
1990s in some countries has raised concerns as to whether the vaccines and the vaccination programs 
have been effective [43].  An intensive and systematic CSF vaccination program in the backyard 
production system in Viet Nam was predicted to be beneficial [39]. 
 
The Situation in Southeast Asia 
The official Disease Control programs of CSF for Indonesia, Myanmar and Viet Nam specified under national and 
ASEAN regional frameworks are summarized in Table 18 [19]. 
 
The Situation in South Asia 
India has adopted a Classical Swine Fever Control Programme included in the existing Scheme of Livestock 
Health and Disease Control. An amount of US$4.7 million has been allocated for the Livestock Health and 
Disease Control Programme for the Twelfth, Five-Year Plan.  The ‘Classical Swine Fever Control Programme (CSF-
CP)’ has been added in the existing scheme of LH&DC during 2014-15. Funds on 100% central share basis are 
provided to the States/Territories for carrying out the vaccination of entire eligible pig population in a phased 
manner starting in the Northeastern States. Depending on the vaccine availability, the scope will be enlarged to 
cover entire country subsequently [46].  
 
As noted, vaccination for CSF is practiced in India, but not to any significant extent in Nepal or Bangladesh.  
Swine is not a prioritized animal species in Bangladesh and is being reared mostly by the lower caste Hindu 
communities mainly hilly area, south and southwestern part of the country. The pigs in this country are the 
indigenous (native) type and husbandry practices are mainly the free reaming roaming or scavenging system.  
Each community includes holdings with only a few pigs that freely roam within the village. As pigs are neglected 
and number less than one million), no vaccine has been introduced and the Department of Livestock Services 
has no plan to vaccinate the swine population. 
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Table 18: Official national and regional control measures adopted by Indonesia, Myanmar and Viet Nam 
 
Control Measures Indonesia Myanmar Viet Nam 
Regional Classical Swine Fever (CSF) Control and Eradication Plan  ✓ ✓ ✓ 
National Classical Swine Fever (CSF) Control and Eradication  ✓ - ✓ 
Regulatory Measures  -  - - 
Disease Surveillance  ✓ - ✓ 
Laboratory Diagnosis  ✓ ✓ ✓ 
Epidemiological Analysis  ✓ ✓ ✓ 
Vaccination  Mandatory - - 
Animal Movement Management  ✓ ✓ ✓ 
Legislation/Policy  ✓ ✓ ✓ 
Research and Development  ✓   
Zoning/ Compartmentalization*  ✓ - ✓ 
Socio-Economics (compensation, budget)  - - - 




Options and Strategies for Vaccination 
The most common CSFV vaccine strain is the Chinese C strain. The GPE– strain, the Thiverval strain, and the 
Mexican PAV strains are also regionally used [47].  The subunit marker vaccines based on the E2 protein are 
produced but are not used for smallholder pig units in ASEAN or SAARC countries.  All strains previously noted 
have DIVA capability except for the Chinese C strain.  The advantages and disadvantages for each strain are 
presented in Table 19. 
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Table 19:  Advantages and disadvantages of CSFV vaccine models 
 




• No clinical signs or replication of 
the challenge virus 4 days post 
vaccination  
• Protection is longer than one year 
and most likely provides lifelong 
immunity  
• Can block transmission of the 
challenge virus from at least 
seven days post vaccination  
• Does not interfere with gestation, 
nor is it harmful to the fetuses, 
and in immunosuppressed sows 
• Effective and reasonable cost 
• Maternal antibodies interfere with the induction 
of vaccinal immunity 
• Lacks DIVA capability  
C Strain  
(cell culture line) 
• Similar to C strain tissue origin in 
safety and efficacy  
• Mass production techniques can 
be applied to increase the 
amount of vaccine available to 
meet demand 
• Effective and reasonable cost 
• Many products lack quality and consistent efficacy 
• Maternal antibodies interfere with the induction 
of vaccinal immunity  
• Lacks DIVA capability 
GPE Strain 
(cell culture) 
• DIVA capability - expression of 
different in vitro markers, e.g. 
interference with the growth of 
Newcastle disease virus in swine 
testicle cell culture  
• Safety and efficacy similar to C 
strain 
• Rarely produces viraemia in 
inoculated swine and is not shed 
in excretions.  
• Protection observed beginning at 
about three days post vaccination  
• Maternal antibodies interfere with the induction 
of vaccinal immunity  
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Well-informed strategies for the selection and implementation of effective CSFV vaccines should be based on 
antigenic, immunologic and epidemiologic information.  Suradhat et al. and other researchers have provided 
reviews, which serve to support planning and decision making related to vaccination strategies for CSF.  Table 20 









• Widely used in Asia 
Thiverval  
(cell culture) 
• DIVA capability - expression of 
different in vitro markers 
• Safe and effective protection 
• Maternal antibodies interfere with the induction 
of vaccinal immunity  
PAV  
(cell culture) 
• Regionally specific application in 
Mexico 
• Maternal antibodies interfere with the induction 
of vaccinal immunity  
• Efficacy of the vaccine differed markedly in field 
conditions compared to under laboratory 
conditions  
E2 subunit marker 
vaccine 
(E2 glycoprotein 
expressed in a 
baculovirus vector)  
 
• DIVA capability - expression of 
different in vitro markers 
• Highly safe with no side effects 
were observed in swine following 
administration of the vaccine 
• Slight tissue reaction at injection 
site 
• Slow onset of immunity - protection of piglets 
against the clinical course of CSF two weeks after 
double vaccination or six weeks after single 
vaccination with the E2 subunit vaccine  
• Experiments assessing horizontal and vertical 
transmission of challenge virus gave varying results 
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Table 20:  Evidence and options to support effective vaccination strategies for CSFV 
 
Evidence Options Reference 
There has been a decline in the number of 
peracute outbreaks due to Genotype 1 
and an increased incidence of subacute 
and chronic CSF outbreaks caused by the 
moderately virulent CSFV, genogroup 2.2.  
The C strain, modified live vaccine (MLV) 
has been regarded as one of the most 
effective CSF vaccines that provides 
complete clinical and virological 
protection, i.e. sterile immunity, within a 
week of vaccination; it is well accepted 
that CSF-MLV can effectively induce 
complete protection against all of the CSFV 
strains  
Suradhat et al., 2001; Van 
Oirschot, 2003 
Pigs vaccinated with the C-strain vaccine 
appear to be completely protected against 
virulent CSFV challenge as early as 1 week 
following vaccination  
When vaccinated pigs were challenged at a 
later stage after vaccination, there was a 
good correlation between the presence of 
neutralizing antibodies at the time of 
challenge and viral protection  
Terpstra and Wensvoort, 
1988; Suradhat et al., 
2001; Van Oirschot, 2003 
 
The C strain vaccine usually induces 
detectable neutralizing antibodies in 
vaccinated pigs 2–3 weeks following 
primary vaccination 
Routine monitoring of SN titers, i.e. 
seroprofile, can still be used for assessing 
the effectiveness of a CSF vaccine program 
in the field. There is a strong 
recommendation for routine monitoring of 
herd immunity to CSFV, in farms situated 
in highly endemic areas. The C strain CSF-
MLV is the vaccine of choice for an 
emergency vaccination protocol 
Precausta et al., 1983; 
Terpstra et al., 1990; Van 
Oirschot, 2003; Graham et 
al., 2012 
A single vaccination of the CSF-MLV, 
including C strain (both lapinized and 
tissue culture derived) and GPE- strains, 
induced complete protection against CSFV 
infection as early as 6 days after 
vaccination. It should be noted that this 
protective effect was observed on the 
condition that the pigs had low levels of 
MDA at the time of vaccination 
The C strain, modified live vaccine (MLV) 
has been regarded as one of the most 
effective CSF vaccines that provides 
complete clinical and virological 
protection, i.e. sterile immunity, within a 
week of vaccination   
 




Combining the C-strain vaccine and a live 
gE-deleted, PRV vaccine resulted in a 
significant reduction in cellular response 
against CSFV, while there were no 
Vaccination of the CSF vaccine combined in 
the same injection with other vaccines 
Suradhat et al., 2001 
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differences in the levels of SN antibody. 
Although the pigs vaccinated with the 
combined vaccine were clinically 
protected against CSFV challenge, there 
were clearly more fever days and 
pathological changes in this group, when 
compared to those from the pigs 
vaccinated with the CSF vaccine alone 
should be systemically tested prior to 
implementation.  
 
E2 subunit vaccine, which mainly activated 
the CSFV-specific T helper cell population 
and the production of neutralizing 
antibodies, confer clinical protection 
against the CSFV challenge 
Protective values of the E2 subunit 
vaccines are inconsistent; vital role of cell-
mediated immunity for controlling viral 
spreading in the challenged animals.  
 
de Smit et al., 2001; 
Uttenthal et al., 2001; 
Dewulf et al., 2002; Van 
Oirschot, 2003 
Oral CSF-MLV vaccination was introduced 
by the European countries for the purpose 
of controlling CSF in wild boars. To obtain 
complete protection, the oral CSF vaccine 
formulation requires the addition of a 
vaccine stabilizer and a higher dose of the 
MLV virus 
Vaccine protocols using a commercially 
available CSF vaccine for oral immunization 
of domestic pigs are not recommended at 
the moment.  
 
Van Oirschot, 2003; Kaden 
et al., 2000). 
Piglets immunized at 5 weeks old 
developed a greater number of CSFV-
specific, IFN-g producing cells in the PBMC 
and higher CSFV-specific, SN titers than 
pigs immunized at 3 weeks old  
Interference by maternal derived 
antibodies (MDA) is the most common 
factor affecting the induction of protective 
immunity against CSFV in the field.  
Suradhat and Damrong- 
watanapokin, 2002 
PRRSV infection significantly interfered 
with induction of CSFV-specific immunity 
which resulted in vaccine failure  
This finding implied that CSF vaccination 
during the active stage of PRRSV infection 
should be avoided. Taken together, the 
above findings emphasize that the 
influence of other pathogens on the 
immune system and/or interactions among 
the pathogens should also be taken into 
consideration. Strict biosecurity and 
routine monitoring of the herd immune 
status will be crucial for preventing such 
complications.  
Suradhat et al., 2006 
CSF vaccine failure that is observed in the 
field is primarily due to a lack of 
understanding of the herd immune status, 
Sharing such information among veterinary 
researchers, swine practitioners and 
farmers, together with a strengthening of 
[43] 
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mechanisms of immunological protection, 
viral pathogenesis, and epidemiology 
the disease surveillance program is 
necessary for a successful CSF preventive 
and control program 
Vaccination in a ring of 2 km radius around 
a detected infection source is as effective 
as ring culling in a 1 km radius. Feasible 
screening scenarios, adapted to the use of 
emergency vaccination, can reduce the 
enhanced risks of (initially) undetected 
farm outbreaks by targeting vaccinated 
farms.  
Results suggest that emergency 
vaccination against CSF can be equally 
effective and safe as pre-emptive culling in 
a densely populated region 
Backer et al., 2009 
Although MLV provide earlier and more 
complete protection than E2 subunit 
vaccines, it has the drawback of not 
allowing DIVA. The marker vaccine of E2 
protein with companion discriminatory 
test to detect antibodies against Erns allows 
DIVA and is a promising strategy for future 
control and eradication of CSF.  
Maternal derived antibody (MDA) is the 
critical factor in impairing the efficacy of 
both MLV and E2 subunit vaccines, so the 
well-designed vaccination programs of 
sows and piglets should be considered 
together; it is necessary to evaluate 
whether the E2 subunit vaccine can 
completely protect against the current 
prevalent strains in the field; ideally a new 
generation of vaccine should be able to 
maintain the high protective efficiency of 
MLV and overcome the problem of 
antigenic variations while allowing for 
DIVA  
Huang et al., 2014; Rijn et 
al., 1997 
The subunit vaccines were found to be less 
efficacious than live attenuated vaccines. 
In addition, the currently available 
discriminatory tests do not provide high 
enough specificity and sensitivity; there is 
an urgent need for more advanced marker 
vaccines and better discriminatory tests 
Development of new DIVA vaccines against 
CSF is hampered by the small market 
potential for these products 
Greiser-Wilke and 
Moennig, 2004 
Although marker vaccines can limit the 
speed and the extent of virus 
dissemination and thus reduce the 
number of animals slaughtered  
Marker vaccines are no substitute for 
sanitary measures. Early detection and 
warning systems and the quick 
implementation of sanitary measures, 
including stamping out, remain key issues 
in the control of highly contagious 
diseases.  
Vannier et al., 2007 
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The virulence, immunogenicity, and 
‘‘marker vaccine’’ properties of the 
generated chimeric CP7_E2alf virus were 
determined in an animal experiment using 
27 pigs  
 
Chimeric CP7_ E2alf may not only serve as 
a tool for a better understanding of 
Pestivirus attachment, entry, and 
assembly, but also represents an 
innocuous and efficacious modified live 
CSFV ‘‘marker vaccine’’  
Reimann et a., 2004; 
Tognon et al., 2010 
Glycoprotein Erns of classical swine fever 
virus (CSFV) was used to rescue CSFV Erns 
deletion mutants based on the infectious 
copy of CSFV strain C. The biochemical 
properties of Erns from this cell line were 
indistinguishable from those of CSFV Erns 
Absence of the antigenic part of Erns in the 
recombinant viral particles can be used to 
differentiate between infected and 
vaccinated animals  
 
Widjojoatmodjo et al., 
2000 
 
CSFV vaccine C-strain and group 2 strains 
circulating in China differ in the 
antigenicity of their E2 glycoproteins.  
 
Need to conduct serological differential 
assays and improvement of 
immunogenicity of novel classical swine 
fever vaccines; There is a clear need for 
efficient and safer marker vaccines to 
assist in the control of future CSF 
outbreaks.  
Chen et al., 2010; Ganges 
et al., 2008 
First report demonstrating the absence of 
a response to vaccination in CSFV 
persistently infected pigs 
Herd virus and serological monitoring of all 
age groups is needed to avoid vaccine 
failure 
Muñoz-González et al., 
2015  
 
PRV (Aujesky’s disease) mutant was used 
as a biologically safe vaccine vector, a 
gD/gE-negative PRV recombinant virus, 
which expresses envelope glycoprotein E2 
of classical swine fever virus was 
constructed.  
Vaccination of pigs showed that the 
recombinant virus was able to protect pigs 
against both Aujeszky’s disease and 
classical swine fever. 
Peeters et al., 1997 
Subunit vaccines, conventional, live 
attenuated CSF vaccines have a rapid 
onset of immunity and are effective at 
preventing transmission of infection, but 
have the disadvantage that it is not 
possible using serological methods (e.g. 
ELISA) to differentiate infected pigs from 
those that have merely been vaccinated; 
commercial E2 subunit vaccines (Marker 
vaccine) have a slower onset of immunity 
These vaccines enable a DIVA strategy to 
be followed thereby facilitating a 
‘vaccination to live’ strategy; the vaccine 
only elicits antibodies against the E2 
glycoprotein and therefore antibodies 
against other CSFV antigens, such as the 
ERNS antigen, can be used as markers of 
infection.  
 
Van Oirschot, 2003; [3];  
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From the evidence presented above, a strategy for CSFV vaccination should consider the following elements: 
• Establish appropriate enabling mechanisms 
o Enabling mechanisms including national policies for pig production, animal identification, official 
control or eradication policy and vaccination;  
o Prioritization of important pig disease priorities (e.g. PRV) regulations and contingency plans for 
CSF, including provisions for zoning and compartmentalization; 
o Laboratory and epidemiological capacity to implement seromonitoring and virus surveillance 
programs; 
o On going communication and information sharing among public, private sectors to raise 
awareness and mobilize local communities to develop and monitor program progress and 
effectiveness; 
o Conduct risk assessments and cost-benefit studies to evaluate the proper use of culling and 
vaccination; 
• Evaluate the presence of all immunosuppressive disease agents such as PRRS routinely as a normal 
component of assessing risk and designing the vaccine program including seromonitoring.  This will be 
critical to address in Viet Nam, Indonesia, Myanmar and India where PRRS has significant health, social 
and economic impacts. 
• Conduct risk assessments and develop effective vaccine planning and delivery systems from national to 
the local level to meet national objectives within the OIE standards; 
and reduce, but may not completely 
prevent, viral shedding and transplacental 
infection 
The main stumbling block to using 
vaccination as a control measure is the 
potential impact on trade; the main 
disadvantage of the E2 marker vaccine 
was that protection was only complete 3 
weeks after vaccination, which would 
diminish its usefulness as an emergency 
vaccine 
Subunit marker (DIVA) vaccines against CSF 
with a companion diagnostic test to trace 
residual infections by detecting antibodies 
not induced by the vaccine have been 
developed; more efficacious DIVA 
technology are ongoing, because the 
immune response is delayed and less 
protective than that to the live attenuated 
vaccines Research is also directed towards 
improving the tests used to distinguish 
naturally infected and vaccinated animals 
[34]; Moormann et al., 
2000; Beer et al., 2007; 
Zhao et al., 2008 
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• Utilize the appropriate type of vaccines under each of the following epidemiological contexts: 
o Free areas of CSFV with Trade Access: Develop a control strategy without prophylactic 
vaccination but establish legal provisions for emergency vaccination scenarios [34]; 
o Endemic Areas:  Modified live ‘C’ type vaccine routine use in endemic areas with rapid onset of 
cell mediated immunity within 6 days [43]; or alternatively, use of E2 subunit vaccines [34]; 
o Emergency Scenarios: Rapid diagnosis is crucial for the control of outbreaks. The combined use 
of culling and emergency vaccination during epidemic incidents in areas with high density pig 
populations can be further considered to control and eradicate the disease [40][42];  
o Progressive elimination and freedom from CSFV:  E2 subunit marker vaccines can used to DIVA 
along with zoning and compartmentalization approaches for the final removal of the need for 
vaccination [3]. 
 
Table 21 presents the official prevention and control policies from a survey of the 20 selected countries under 
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(yes/no) (yes/no) (yes/no) 
Country 
   
Compulsory 
vaccination 

























         
Ethiopia 
         
Ivory Coast OUI PASSIF MAIS 
ACTIF EN CAS 
D’EPIZOOTIE 
OUI NON 
   
NON 
 
Kenya no Yes, passive no NA NA NA NA NA NA 
Madagascar 
         
Malawi YES YES(PASSIVE) NO N/A N/A N/A N/A N/A N/A 
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Mozambique 
         
Rwanda 
         
Senegal 
         
South Africa 
         
Tanzania 
         
Uganda N/A N/A N/A N/A N/A N/A N/A N/A N/A 
Zambia Yes Yes - passive Yes N/A N/A N/A N/A No No 
Bangladesh Yes No No No No No No No No 
India 
         
Nepal Yes yes/passive No No combination both Pigs N/A N/A 
Indonesia 
         
Myanmar yes yes(passive) no no Farmers Both pig no yes 
Vietnam Yes Yes/Passive No Yes Farmers Private 
vaccinators 
Pigs No Yes 
1Surveillance: is the systematic on going collection, collation and analysis of data and the timely dissemination of information to those who need to know so that 
action can be taken.  
2Control: a programme which is approved, and managed or supervised by the Veterinary Authority of a country for the purpose of controlling a 
vector, pathogen or disease by specific measures applied throughout that country, or within a zone or compartment of that country. 
Classical Swine Fever | Monograph 07 












South Asia, less than 2% pigs are vaccinated against CSF, mainly due to the lack of availability of vaccine and 
poor awareness among smallholders. In Southeast Asia, 50-90% of pigs (the nearer to the town, the higher the 
percentage) are vaccinated against CSF [45]. Besides vaccination, there are policies for movement control of 
diseased animal and slaughter of diseased pigs in certain countries including Thailand, Vietnam, and Malaysia [7].  
 
Commercial vaccines manufactured in Africa and Asia  
 




Strengths Weaknesses Opportunities Threats 






GPE strain is a marker 
vaccine compatible 
with DIVA using 
CHEKIT diagnostic and 
differentiating test 
kits;  
Requires countries to 
have proper test kits 
Widely used in Asia; 
DIVA capacity during 











Thiverval strain with 
rapid onset of 
immunity could be 
given as early as 5 days 
of age; twice annual 
vaccination; vaccinate 
3-6 weeks before 
farrowing 
Do not use during 
gestation; Short 
duration of immunity 
– 4 months; must be 
given at 35 days of 
age and then boost 
3-4 weeks later; 50 
Widely used in Asia; 
From 1 single shot 
(from 35 days of age) 
in low risk conditions 
(non-endemic 
situation, isolated 
farms) to a 2 shots 
programme (1st shot 
from 3 to 4 weeks of 
None 
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dose vials; keep 
refrigerated 2-8℃ 
age, completed with a 
2nd shot 3 weeks 
later) in high-risk 
conditions(CSF 
endemic situation, 







clinical disease and 
from becoming a 
carrier-shedder for 
older pigs and 
congenitally infected 
piglets; China CL strain 
lapinized tissue 
derived with 24 
months of long term 
protection; 10, 20 and 
50 dose vials; safe and 
effective; safe in 
pregnant sows 
Lacks DIVA capability Widely accepted and 
used due to safety and 
efficacy 
Lacks DIVA capacity 
in late stages of virus 
eradication 
Porcilis CSF Live, 





duration of immunity 
Fattening pigs: single 
dose at 1-2 months of 
age, depending on the 
level of maternally 
derived antibodies 
(MDA). Breeding pigs: 
vaccinate at 1-2 
months of age, 
depending on MDA. 
Revaccinate 6 months 
later and then once a 
year; smaller dose of 1 
ml intramuscular 
Must have laboratory 
test kits and 
capacity; 50 dose 
vials; store at 2-8℃ 











Vaccinate at 6 weeks 
and then annually; 10 
dose vials available; 
immunity develops 
Not safe for use 
during gestation; 
keep refrigerated 
Potential access to 
African markets; DIVA 
in late stages of 
eradication  
Acceptability by 
farmers of safety 
concerns during 
gestation 
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after 5 days; 
protection for 
European strains of 
CSF; 12 months 









Thermostable C strain 
attenuated HCV virus 
liquid and some heat 
resistant protective 
agent; Protection 
begins 4 days following 
vaccination with 
duration of 12 months; 
piglets should be 
vaccinated twice at 21-
30 days old and 
around 65 days old 
respectively; 
replacement gilts 
should be vaccinated 
twice before breeding 
and the interval of the 
two vaccinations is 3 
weeks. 
Store at 2-8℃ Stable once the 
vaccine is 
reconstituted 
















C Strain with rapid 
onset of immunity; 
injected pigs will get 
immunity after 4 days 
of injection. For the 
Piglets without 
maternal antibody 
after weaning, the 
immune period lasts 
for 12 mouths; piglets 
without maternal 
antibody after weaning 
can be vaccinated just 
once. Otherwise, the 
piglets should be 
vaccinated twice at 21-
30 days old and 
Requires storage 
temperature at 
minus 15℃ without 
sunshine 
Potential market 
access in Asia 
Lacks DIVA capacity 
in late stages of virus 
eradication 
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LIVING; PK-15 cell 







Vaccinate at 6 - 8 
weeks and with a 
booster dose 3 - 4 
weeks later 
Sows and gilts should 
be vaccinated before 
mating. 
Boars should be 
vaccinated twice a 
year; 5 dose, 10 dose 
and 20 dose pack 
No claims of safety 
except no tissue 
reaction; Store below 
8°C 
Potential market 
access in Asia 
Uncertainties related 













C Strain; Prevention of 
Classical Swine Fever. 
The injected pigs will 
get immunity after 4 
days of injection. For 
the Piglets without 
maternal antibody 
after weaning, the 
immune period lasts 
for 18 months 
Preserved at a 
temperature at 
minus 15℃. The 
vaccine will be 




access in Asia 
Lacks DIVA capacity 





(Rabbit Origin); 1 
ml intramuscular 
or subcutaneous; 
each dose with at 
least 0.01g swine 




Co., Ltd. (China) 
C Strain; Prevention of 
swine fever and strong 
immunity is produced 
in 4 days after 
vaccination and last for 
18 months for weaned 
piglets without 
maternal antibody; 
Safe: The piglet before 
weaning can be 
inoculated with 4 
doses of the vaccine, 
so as to prevent the 
interference of 
maternal antibody; 
Delivered and stored 
under 8℃ 
Potential smallholder 
market access in Asia 
Lacks DIVA capacity 
in late stages of virus 
eradication 
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Live (Cell Line 
Origin); CSFV 
lapinized strain 






Co., Ltd. (China) 
 
In the regions without 
the prevalence of 
CSFV, the Piglets 
without maternal 
antibody after weaning 
can be vaccinated just 
once; otherwise, the 
piglets should be 
vaccinated twice at 21-
30 days old and 
around 65 days old 
respectively; The 
vaccine will be 
efficacious if stored for 
18 months. 
Keep at a 
temperature of 
minus 15℃ without 
sunshine.  
Potential market 
access in Asia 
Lacks DIVA capacity 
in late stages of virus 
eradication 
E2 subunit marker vaccine 
Porcilis Pesti, 
Inactivated  water 









two doses separated 
by 4 weeks. 
Revaccination: every 6 
months. 
May not prevent 
transplacental 
transmission of 
Classical swine fever 
field virus from the 
sow to fetuses; slow 
onset of immunity; 
mild transient tissue 
reaction at injection 
site. 










Classical Swine Fever | Monograph 07 










Name Strain or 
type 
Country of origin Doses imported  Doses imported Doses imported Doses imported 
2015 2014 2013 2012 
Burkina Faso 
       
Ethiopia 
       
Ivory Coast 
       
Kenya 
       
Madagascar 
       
Malawi 
       
Mali 
       
Mozambique 
       
Rwanda 
       
Senegal 
       
South Africa 
       
Tanzania 
       
Uganda NA NA NA NA NA NA NA 
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Bangladesh No No No No No No No 
India 
       
Nepal 
       
Indonesia 
       
Myanmar Pestifer Chinese 
Strain 
China 112,000  304,000  4,590,000  30,000  
Vietnam 
  
• Komipharm International 
• Choongang Vaccine 
Laboratory 
• Daesung Microbiological Lab 
• Formosa Biomedical 
• Kaohsiung Biological Product 
• Vaccines and 
Pharmaceuticals Sdn. Bhd 
• Kyoritsu Seiyaku Corporation 
• Merial 
• Ceva Sante Animale 
• Bestar Laboratories 
• Chengdu Medical E&P of 
China Animal Husbandry 
• Guangdong Dahuanong 
Animal Health Products 
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The optimal CSF vaccine should have the following general characteristics: short- and long-term safety for target 
and non-target species (especially for oral vaccines); stability, rapid induction of a stable, preferably life-long 
immunity; efficacy against all strains and types of field viruses; full clinical protection and protection against 
carrier states; and prevention of horizontal and vertical transmission. Furthermore, marker vaccines will require 
reliable discriminatory tests [3]. Blome et al. described several research initiatives undertaken by the European 
Union funding including: 1) ‘Immunological mechanisms of protection against CSFV: towards the development of 
new efficacious marker vaccines’; and 2) ‘Identification of efficacious delivery systems for recombinant and 
nucleic acid construct vaccines’.  The third EU-funded project involves investigation of vaccination strategies in 
wild boar [47].  A review of the gaps is available and results are included in the following Target Product Profile 
[51]. 
 
Target Product Profile 
A target product profile for live attenuated vaccines relevant to smallholder pig production is presented to 
accommodate the different epidemiological stages inherent for prevention, control and eradication. 
 
Attribute Minimum (currently available 
vaccine) 
Ideal 
Antigen Lapinized C strain Cell culture C strain with marker 
Indication for use Prevention of classical swine fever 
for 1) adult carrier pigs; 2) 
congenitally infected piglets 
Same 
Recommended species Pigs Same  or oral 
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Recommended dose 1-2 ml  1 ml 
Pharmaceutical form Rabbit tissues (fat or spleen) 
monovalent 




Intramuscular, intradermal or 
subcutaneous 
Same 
Regimen – primary 
vaccination 
1-8 weeks (7-56 days) 1-5 weeks (7-35 days) 
Regimen – booster 3-4 weeks later 3-4 weeks after first vaccination followed by 
boosters based on specific village herd serological 
profiles with consideration for co-circulating 
immunosuppressive diseases e.g. PRRS. 
Epidemiological 
relevance and use for 
smallholders 
Currently useful for prevention and 
control in endemic or emergency 
situations; No DIVA capability 
Prevention, control and eradication with DIVA 
capability 
Recommended age at 
first vaccination 
35 – 56 days of age As early as 35 days of age based on herd profiling 
Onset of immunity Cell immune response in 4-6 days 
post vaccination 
Same 
Duration of immunity 4-48 months 48 months ideally 
Expected efficacy 99-100% Same  
Expected safety 99-100% Same 
Withdrawal period 0 Same 
Special requirements 
for animals 
Base e of first vaccine on 
seromonitoring titers of sows for 
CSFV and PRRS; safe for use in 




Handle and inject safely to avoid 
possible tissue reaction or 
anaphylaxis 
Same 
Package size 10-50 doses per vial Same 
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Price to end user US$ 0.16-0.20 per dose US$ 0.16 per dose 
Storage condition and 
shelf-life as packages 
for sale 
Require storage without exposure to 
ultraviolet light either at: 1) 2-8oC; 
or 2) -15oC 
Thermostable vaccine at ambient temperature in 
storage and during use 
In-use stability Either use within 3 hours or longer 
thermostability 




Key Conclusions Related to Vaccination 
The following conclusions are presented with respect to vaccination for classical swine fever for smallholder 
pigs: 
• The CSF vaccine selected must be fit for purpose in relation to the epidemiological context of Asian 
countries; 
• A CSF vaccination program should be optimized by including veterinary and farmer education herd 
related to seromonitoring prior to, during and following a vaccination campaign in order to assess: 1) the 
chronic form of CSF; 2) the presence of immunosuppressive diseases such as PRRS; as well as 3) the 
timing of vaccination related to the decay of maternally derived antibodies; 
• The CSF ‘C’ and GPE strains are safe and effective vaccines which cover a broad range of CSFV genotypes 
and serve an important role in the prevention and control of CSF in Asia and Europe; 
o The need for a marker to expand the DIVA capability for ‘C’ strain; 
o Further basic research and field testing of GPE marker vaccine including field trials; 
o Transition from the lapinized form to rabbit cell culture lines of ‘C’ strain requires further 
support and collaboration in both Southeast and South Asia. 
• Additional research is required in the following areas: 
o Basic research of immunological mechanisms to optimize subunit marker vaccines in the longer 
term; 
o Experimental and field studies on new subunit marker vaccines which can improve their efficacy 
against a broader range of genotypes; 
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o Assess the need for and feasibility to develop multivalent vaccines for CSF and other priority pig-
specific diseases such as PRV and PRRS; 
o Epidemiological research to assess the role that wild pigs and feral pigs may play in the 
introduction and transmission in Asia; 
o Assess the performance of field based test kits for antibody and antigen detection under 
conventional and DIVA applications. 
• Work within a One Health approach for CSF vaccine development and implementation within the 
context of zoonotic pig diseases that are important to the communities including influenza A H1N1, 
Japanese encephalitis, Streptococcus suis and cysticercosis. 
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The OIE data from South and Southeast Asia may not be entered in a standardized format and grossly 
underestimates the incidence and prevalence of CSFV based on recent FAO surveys of epidemiology and 
laboratory data quality in the region of Asia and the Pacific [52].  Based on the limited number of CSF studies 
supported by ILRI and AAHL the burden of disease due to CSF in Asia is significant, impacting the poorest of the 
poor.  Although prevalence and socioeconomic studies of CSF were conducted in India and Lao PDR, there is 
limited published information related to CSF in Viet Nam, Indonesia, Bangladesh and Nepal.  The author 
contacted epidemiologists in these countries to seek additional information and confirmation.  ASEAN has taken 
a systematic approach to promote collaborative policies and research on CSF where leading countries such as 
Viet Nam, Philippines and Thailand play important roles and this should be considered in the subsequent phases 
of the LVIF project.  
 
Gaps in knowledge or capacity impacting strategic planning and effective implementation 
The key gaps and solutions that need to be addressed prior to developing a potential vaccine: 
Short term: 
• Assess and optimize the existing C strain tissue culture lines for wider use; 
• Build vaccine production capacity for thermostable cell culture C strain vaccine based on tissue culture 
to increase vaccine production capacity, especially in India and Viet Nam; 
• Conduct field trails with documented assessments to test the effectiveness of vaccines and diagnostic 
tests;  
• Conduct pilot projects that include education of veterinarians, paraveterinarians and farmers on the 
proper use and application of vaccines and diagnostic tests. 
Medium term: 
• Support the development of C strain vaccines with DIVA capability with the private sector involvement 
for cost effective and sustainable eradication of CSF; 
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• Develop a cheap and effective test kit for virus detection for smallholders to meet the challenge of the 
predominant genotypes in Asia from the acute form (genotype 1) to the chronic form (genotype 2) 
which results in silent carriers. 
• Conduct epidemiological research and risk assessments in Asia at the interface of commercial pig - 
smallholder pig production units - wild boar and feral pigs; 
Long term: 
• Further develop subunit marker vaccines that can eliminate all three genotypes; 
• Continue basic research immunological properties of all C strain vaccines and subunit marker vaccines;  
• Assess needs for oral vaccines for wild and expand the use to backyard pigs in Asia. 
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